Acinic cell carcinoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
===Prevalence=== | ===Prevalence=== | ||
In western countries, salivary gland carcinomas account for 4000 out of 100000 of all head and neck carcinomas, and approximately 80% of those occurring in parotid gland. one out of six parotid gland cancer is acinic cell carcinoma.<ref name="Al-Mamganivan Rooij2012">{{cite journal|last1=Al-Mamgani|first1=Abrahim|last2=van Rooij|first2=Peter|last3=Verduijn|first3=Gerda M.|last4=Meeuwis|first4=Cees A.|last5=Levendag|first5=Peter C.|title=Long-term Outcomes and Quality of Life of 186 Patients With Primary Parotid Carcinoma Treated With Surgery and Radiotherapy at the Daniel den Hoed Cancer Center|journal=International Journal of Radiation Oncology*Biology*Physics|volume=84|issue=1|year=2012|pages=189–195|issn=03603016|doi=10.1016/j.ijrobp.2011.11.045}}</ref> | In western countries, salivary gland carcinomas account for 4000 out of 100000 of all head and neck carcinomas, and approximately 80% of those occurring in parotid gland. one out of six parotid gland cancer is acinic cell carcinoma.<ref name="Al-Mamganivan Rooij2012">{{cite journal|last1=Al-Mamgani|first1=Abrahim|last2=van Rooij|first2=Peter|last3=Verduijn|first3=Gerda M.|last4=Meeuwis|first4=Cees A.|last5=Levendag|first5=Peter C.|title=Long-term Outcomes and Quality of Life of 186 Patients With Primary Parotid Carcinoma Treated With Surgery and Radiotherapy at the Daniel den Hoed Cancer Center|journal=International Journal of Radiation Oncology*Biology*Physics|volume=84|issue=1|year=2012|pages=189–195|issn=03603016|doi=10.1016/j.ijrobp.2011.11.045}}</ref><ref name="Vander PoortenTriantafyllou2015">{{cite journal|last1=Vander Poorten|first1=V.|last2=Triantafyllou|first2=A.|last3=Thompson|first3=L. D. R.|last4=Bishop|first4=J.|last5=Hauben|first5=E.|last6=Hunt|first6=J.|last7=Skalova|first7=A.|last8=Stenman|first8=G.|last9=Takes|first9=R. P.|last10=Gnepp|first10=D. R.|last11=Hellquist|first11=H.|last12=Wenig|first12=B.|last13=Bell|first13=D.|last14=Rinaldo|first14=A.|last15=Ferlito|first15=A.|title=Salivary acinic cell carcinoma: reappraisal and update|journal=European Archives of Oto-Rhino-Laryngology|volume=273|issue=11|year=2015|pages=3511–3531|issn=0937-4477|doi=10.1007/s00405-015-3855-7}}</ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
Revision as of 12:34, 9 September 2019
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acinic cell carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acinic cell carcinoma epidemiology and demographics |
|
Acinic cell carcinoma epidemiology and demographics in the news |
|
Blogs on Acinic cell carcinoma epidemiology and demographics |
|
Risk calculators and risk factors for Acinic cell carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Acinic cell carcinoma can appear at any age however, it is common in children.
- Acinic cell carcinoma appears in all age groups, but presents at a younger median age (approximately 52 years) than most other salivary gland cancers.
- Women are more frequently diagnosed than men.
- Occurrences in children are quite common.
- According to the National Cancer Data Base Report on cancer of the head and neck in the United States, the parotid gland was the predominant site of origin (86.3%) for reported acinic cell carcinoma.
- Regional and distant metastasis, high grade, and large tumor size were all more common among patients older than 30.
- No ethnic or racial predilection showed an association with acinic cell carcinoma.
Epidemiology and Demographics
Incidence
Prevalence
In western countries, salivary gland carcinomas account for 4000 out of 100000 of all head and neck carcinomas, and approximately 80% of those occurring in parotid gland. one out of six parotid gland cancer is acinic cell carcinoma.[1][2]
Case-fatality rate/Mortality rate
Age
Race
Gender
Region
Developed Countries
Developing Countries
References
- ↑ Al-Mamgani, Abrahim; van Rooij, Peter; Verduijn, Gerda M.; Meeuwis, Cees A.; Levendag, Peter C. (2012). "Long-term Outcomes and Quality of Life of 186 Patients With Primary Parotid Carcinoma Treated With Surgery and Radiotherapy at the Daniel den Hoed Cancer Center". International Journal of Radiation Oncology*Biology*Physics. 84 (1): 189–195. doi:10.1016/j.ijrobp.2011.11.045. ISSN 0360-3016.
- ↑ Vander Poorten, V.; Triantafyllou, A.; Thompson, L. D. R.; Bishop, J.; Hauben, E.; Hunt, J.; Skalova, A.; Stenman, G.; Takes, R. P.; Gnepp, D. R.; Hellquist, H.; Wenig, B.; Bell, D.; Rinaldo, A.; Ferlito, A. (2015). "Salivary acinic cell carcinoma: reappraisal and update". European Archives of Oto-Rhino-Laryngology. 273 (11): 3511–3531. doi:10.1007/s00405-015-3855-7. ISSN 0937-4477.